Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines

키워드

참고문헌 (66)

1. vidence-Based Medicine Working Group, "Evidence-based medicine. A new approach to teaching the practice of medicine", JAMA, 268, pp.2420~2425 (1992)
2. American Psychiatric Association, "Practice guideline for major depressive disorder in adults. American Psychiatric Association", Am J Psychiatry, 150(4 Suppl), pp.1~26 (1993)
3. American Psychiatric Association, "Practice guideline for the treatment of patients with bipolar disorder", Am J Psychiatry, 151(12 Suppl) (1994), American Psychiatric Association
4. Sachs GS, "The expert consensus guideline series: medication treatment of bipolar disorder 2000", Postgrad Med, (Spec No), pp.1~104 (2000)
5. Kahn DA, "Medication treatment of bipolar disorder 2000 : a summary of the expert consensus guidelines", J Psychiatr Pract, 6, pp.197~211 (2000)
6. Suppes T, "The Texas implementation of medication algorithms : update to the algorithms for treatment of bipolar I disorder", J Clin Psychiatry, 66, pp.870~886 (2005)
7. Goodwin GM, "Evidence-based guidelines for treating bipolar disorder : recommendations from the British Association for Psychopharmacology", J Psychopharmacol, 17, pp.149~173 (2003)
8. Parker GB, "Is there consensus across international evidence-based guidelines for the management of bipolar disorder", Acta Psychiatr Scand, 135, pp.515~526 (2017)
9. Hee Ryung Wang, "Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines", Clinical Psychopharmacology and Neuroscience, 15(3), pp.199~209 (2017), 대한정신약물학회[DOI]
10. Jeong Seok Seo, "Korean Medication Algorithm for Depressive Disorders 2017: Third Revision", Clinical Psychopharmacology and Neuroscience, 16(1), pp.67~87 (2018), 대한정신약물학회[DOI]
11. The Executive Committee of Korean Bipolar Medication Algorithm Project for Bipolar Disorder, "The Korean medication guideline for bipolar disorder" (2002), Jungang Moonwhasa
12. Jon DI, "Algorithm-driven treatment for bipolar disorder in Korea : Clinical feasibility, efficacy, and safety", Int J Psychiatry Clin Pract, 13, pp.122~129 (2009)
13. Jon DI, "Revised Korean medication algorithm for bipolar disorder", World J Biol Psychiatry, 10, pp.846~855 (2009)
14. Shin YC, "Korean medication algorithm for bipolar disorder : second revision", Asia Pac Psychiatry, 5, pp.301~308 (2013)
15. Woo YS, "Korean Medication Algorithm Project for Bipolar Disorder : third revision", Neuropsychiatr Dis Treat, 11, pp.493~506 (2015)
16. Young Sup Woo, "Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision", Clinical Psychopharmacology and Neuroscience, 16(4), pp.434~448 (2018), 대한정신약물학회[DOI]
17. Goodwin GM, "Evidence-based guidelines for treating bipolar disorder : Revised third edition recommendations from the British Association for Psychopharmacology", J Psychopharmacol, 30, pp.495~553 (2016)
18. Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)2018 guidelines for the management of patients with bipolar disorder", Bipolar Disord, 20, pp.97~170 (2018)
19. Fountoulakis KN, "The International College of Neuro-Psychopharmacology(CINP)treatment guidelines for bipolar disorder in adults(CINP-BD-2017), part 3 : the clinical guidelines", Int J Neuropsychopharmacol, 20, pp.180~195 (2017)
20. Fountoulakis KN, "The International College of Neuro-Psychopharmacology(CINP)treatment guidelines for bipolar disorder in adults(CINP-BD-2017), part 2 : review, grading of the evidence, and a precise algorithm", Int J Neuropsychopharmacol, 20, pp.121~179 (2017)
21. Fountoulakis KN, "The International College of Neuropsychopharmacology(CINP)treatment guidelines for bipolar disorder in adults(CINP-BD-2017), part 1 : background and methods of the development of guidelines", Int J Neuropsychopharmacol, 20, pp.98~120 (2017)
22. Fountoulakis KN, "The International College of Neuropsychopharmacology(CINP)treatment guidelines for bipolar disorder in adults(CINP-BD-2017), part 4 : unmet needs in the treatment of bipolar disorder and recommendations for future research", Int J Neuropsychopharmacol, 20, pp.196~205 (2017)
23. National Collaborating Centre for Mental Health (UK), "Bipolar disorder: The NICE guideline on the assessment and management of bipolar disorder in adults, children and adolescents, in primary and secondary care", British Psychological Society, ~ (2014)
24. Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders : update 2009 on the treatment of acute mania", World J Biol Psychiatry, 10, pp.85~116 (2009)
25. Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders : update 2010 on the treatment of acute bipolar depression", World J Biol Psychiatry, 11, pp.81~109 (2010)
26. Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders : update 2012 on the long-term treatment of bipolar disorder", World J Biol Psychiatry, 14, pp.154~219 (2013)
27. American Psychiatric Association, "Practice guideline for the treatment of patients with bipolar disorder (revision)", Am J Psychiatry, 159(4 Suppl), pp.1~50 (2002)
28. Goodwin GM, "Evidence-based guidelines for treating bipolar disorder : revised second edition--recommendations from the British Association for Psychopharmacology", J Psychopharmacol, 23, pp.346~388 (2009)
29. Sharma V, "Continuation and prophylactic treatment of bipolar disorder", Can J Psychiatry, 42(Suppl 2), pp.92S~100S (1997)
30. Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)guidelines for the management of patients with bipolar disorder : consensus and controversies", Bipolar Disord, 7(Suppl 3), pp.5~69 (2005)
31. Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)guidelines for the management of patients with bipolar disorder : update 2007", Bipolar Disord, 8, pp.721~739 (2006)
32. Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)collaborative update of CANMAT guidelines for the management of patients with bipolar disorder : update 2009", Bipolar Disord, 11, pp.225~255 (2009)
33. Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)collaborative update of CANMAT guidelines for the management of patients with bipolar disorder : update 2013", Bipolar Disord, 15, pp.1~44 (2013)
34. National Collaborating Centre for Mental Health (UK), "Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care", British Psychological Society, ~ (2006)
35. Grunze H, "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression", World J Biol Psychiatry, 3, pp.115~124 (2002)
36. Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders, part II : treatment of mania", World J Biol Psychiatry, 4, pp.5~13 (2003)
37. Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders, part III : maintenance treatment", World J Biol Psychiatry, 5, pp.120~135 (2004)
38. Davis DA, "Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines", CMAJ, 157, pp.408~416 (1997)
39. Lin D, "Polytherapy in bipolar disorder", CNS Drugs, 20, pp.29~42 (2006)
40. Ketter TA, "Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder", J Clin Psychiatry, 69(Suppl 5), pp.9~15 (2008)
41. Bourin MS, "Lithium as add-on to quetiapine XR in adult patients with acute mania : a 6-week, multicenter, double-blind, randomized, placebo-controlled study", Int J Bipolar Disord, 2, pp.14~ (2014)
42. Xu L, "Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania : a randomized controlled study in a Chinese population group", Neuropsychiatr Dis Treat, 11, pp.1265~1271 (2015)
43. Ogawa Y, "Mood stabilizers and antipsychotics for acute mania : a systematic review and meta-analysis of combination", augmentation therapy versus monotherapy, 2014, pp.28, 989~1003
44. In Hee Shim, "Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors", Clinical Psychopharmacology and Neuroscience, 15(3), pp.248~255 (2017), 대한정신약물학회[DOI]
45. Hu C, "Trajectories of body mass index change in first episode of mania : 3-year data from the systematic treatment optimization program for early mania(STOP-EM)", J Affect Disord, 208, pp.291~297 (2017)
46. Baldessarini RJ, "Factors associated with treatment nonadherence among US bipolar disorder patients", Hum Psychopharmacol, 23, pp.95~105 (2008)
47. Cipriani A, "Comparative efficacy and acceptability of antimanic drugs in acute mania : a multiple-treatments meta-analysis", Lancet, 378, pp.1306~1315 (2011)
48. Lindström L, "Maintenance therapy with second generation antipsychotics for bipolar disorder-a systematic review and meta-analysis", J Affect Disord, 213, pp.138~150 (2017)
49. Mojtabai R, "National trends in psychotropic medication polypharmacy in office-based psychiatry", Arch Gen Psychiatry, 67, pp.26~36 (2010)
50. Cruz N, "Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression : a meta-analysis", Int J Neuropsychopharmacol, 13, pp.5~14 (2010)
51. Selle V, "Treatments for acute bipolar depression : meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics", Pharmacopsychiatry, 47, pp.43~52 (2014)
52. Fountoulakis KN, "A systematic review of the evidence on the treatment of rapid cycling bipolar disorder", Bipolar Disord, 15, pp.115~137 (2013)
53. Vieta E, "Pharmacological management of bipolar depression : acute treatment, maintenance, and prophylaxis", CNS Drugs, 27, pp.515~529 (2013)
54. Young Sup Woo, "Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea", Clinical Psychopharmacology and Neuroscience, 15(2), pp.177~180 (2017), 대한정신약물학회[DOI]
55. Solmi M, "Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression : a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials", CNS Spectr, 21, pp.403~418 (2016)
56. Calabrese JR, "Bipolar rapid cycling : focus on depression as its hallmark", J Clin Psychiatry, 62(Suppl 14), pp.34~41 (2001)
57. Zupancic ML, "Role of atypical antipsychotics in rapid cycling bipolar disorder : a review of the literature", Ann Clin Psychiatry, 23, pp.141~149 (2011)
58. Poo SX, "Atypical anti-psychotics in adult bipolar disorder : current evidence and updates in the NICE guidelines", Psychiatr Danub, 26(Suppl 1), pp.322~329 (2014)
59. Goldberg JF, "The American Society of Clinical Psychopharmacology survey of psychopharmacologists’ pratice patterns for the treatment of mood disorders", Depress Anxiety, 32, pp.605~613 (2015)
60. Tohen M, "Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine", Am J Psychiatry, 163, pp.247~256 (2006)
61. Tohen M, "Olanzapine versus lithium in the maintenance treatment of bipolar disorder : a 12-month, randomized, double-blind, controlled clinical trial", Am J Psychiatry, 162, pp.1281~1290 (2005)
62. Quiroz JA, "Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder", Biol Psychiatry, 68, pp.156~162 (2010)
63. Vieta E, "A randomized, double-blind, placebocontrolled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder", Eur Neuropsychopharmacol, 22, pp.825~835 (2012)
64. Chan HW, "Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder : a 1-year retrospective cohort study", J Affect Disord, 205, pp.360~364 (2016)
65. Calabrese JR, "Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder : a double-blind, placebo-controlled, 52-week randomized withdrawal study", J Clin Psychiatry, 78, pp.324~331 (2017)
66. Calabrese JR, "Symptoms and functioning with aripiprazole oncemonthly injection as maintenance treatment for bipolar I disorder", J Affect Disord, 227, pp.649~656 (2018)

관련 논문AI추천